Concepedia

Patrick F. Finn

PF

16

Publications

922

Citations

14

H-Index

2005

Active since

Affiliations

Moderna Therapeutics (United States)(Current)

Tufts University

University College London

National Institute for Health Research

University of Southampton

Patrick F. Finn is an author at Moderna Therapeutics (United States) specializing in medicine, cell biology, and biochemistry.

ORCID

Top concepts

Publications per year

2005–2024

16

Publications

16

Systemic mRNA Therapy for the Treatment of Fabry Disease: Preclinical Studies in Wild-Type Mice, Fabry Mouse Model, and Wild-Type Non-human Primates

Xuling Zhu, Ling Yin, Matt Theisen et al. · The American Journal of Human Genetics · 2019 · 156 citations · Full text

, , +5

Effects of Small Molecules on Chaperone-Mediated Autophagy

Patrick F. Finn, Nicholas T. Mesires, Michaela Vine et al. · Autophagy · 2005 · 148 citations · Full text

, , +18

Ketone Bodies Stimulate Chaperone-mediatedAutophagy

Patrick F. Finn, J. Fred Dice · Journal of Biological Chemistry · 2005 · 137 citations · Full text

, , +20

mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency

Jingsong Cao, An Ding, Mikel Galduroz et al. · Molecular Therapy · 2019 · 71 citations · Full text

Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4 mouse model of PFIC3

Guangyan Wei, Jingsong Cao, Pinzhu Huang et al. · Journal of Hepatology · 2020 · 70 citations · Full text

Rows per page

1–5 of 16